Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Jul;88(1):1-11.
doi: 10.1002/ana.25807.

COVID-19: A Global Threat to the Nervous System

Affiliations
Review

COVID-19: A Global Threat to the Nervous System

Igor J Koralnik et al. Ann Neurol. 2020 Jul.

Abstract

In less than 6 months, the severe acute respiratory syndrome-coronavirus type 2 (SARS-CoV-2) has spread worldwide infecting nearly 6 million people and killing over 350,000. Initially thought to be restricted to the respiratory system, we now understand that coronavirus disease 2019 (COVID-19) also involves multiple other organs, including the central and peripheral nervous system. The number of recognized neurologic manifestations of SARS-CoV-2 infection is rapidly accumulating. These may result from a variety of mechanisms, including virus-induced hyperinflammatory and hypercoagulable states, direct virus infection of the central nervous system (CNS), and postinfectious immune mediated processes. Example of COVID-19 CNS disease include encephalopathy, encephalitis, acute disseminated encephalomyelitis, meningitis, ischemic and hemorrhagic stroke, venous sinus thrombosis, and endothelialitis. In the peripheral nervous system, COVID-19 is associated with dysfunction of smell and taste, muscle injury, the Guillain-Barre syndrome, and its variants. Due to its worldwide distribution and multifactorial pathogenic mechanisms, COVID-19 poses a global threat to the entire nervous system. Although our understanding of SARS-CoV-2 neuropathogenesis is still incomplete and our knowledge is evolving rapidly, we hope that this review will provide a useful framework and help neurologists in understanding the many neurologic facets of COVID-19. ANN NEUROL 2020;88:1-11 ANN NEUROL 2020;88:1-11.

PubMed Disclaimer

Conflict of interest statement

Nothing to report.

Figures

FIGURE 1
FIGURE 1
Mechanisms of severe acute respiratory syndrome‐coronavirus type 2 (SARS‐CoV‐2) neuropathogenesis. SARS‐CoV‐2 pathogenic effects on the nervous system are likely multifactorial, including manifestations of systemic disease, direct neuro‐invasion of the central nervous system (CNS), involvement of the peripheral nervous system (PNS) and muscle, as well as through a postinfectious, immune‐mediated mechanism. MOF = multi‐organ failure; GBS = Guillain‐Barre syndrome. *CNS inflammation (CSF pleocytosis and proteinorrachia) with no evidence of direct viral infection of CNS; §direct evidence of viral invasion (reverse transcriptase‐polymerase chain reaction positive [RT‐PCR+], biopsy); ADEM = acute disseminated encephalomyelitis; ANE = acute necrotizing encephalopathy. [Color figure can be viewed at www.annalsofneurology.org]

References

    1. Sanche S, Lin YT, Xu C, et al. The novel coronavirus, 2019‐nCoV, is highly contagious and more infectious than initially estimated. medRxiv 2020. 10.1101/2020.02.07.20021154. - DOI
    1. Wu F, Zhao S, Yu B, et al. A new coronavirus associated with human respiratory disease in China. Nature 2020;579:265–269. - PMC - PubMed
    1. Andersen KG, Rambaut A, Lipkin WI, et al. The proximal origin of SARS‐CoV‐2. Nat Med 2020;26:450–452. - PMC - PubMed
    1. Uhlén M, Fagerberg L, Hallström BM, et al. Tissue‐based map of the human proteome. Science 2015;347:1260419. - PubMed
    1. Algahtani H, Subahi A, Shirah B. Neurological complications of Middle East respiratory syndrome coronavirus: a report of two cases and review of the literature. Case Rep Neurol Med 2016;2016:1–6. 10.1155/2016/3502683. - DOI - PMC - PubMed

MeSH terms